|
Sychev D.A., Cherniaeva M.S., Rozhkova M.A., Moiseeva E.A., Pogodina A.A., Bayzel Yu.S., Egorova L.A., Maslennikova O.M., Lomakin N.V.
Safety of direct oral anticoagulants in the treatment of atrial fibrillation in geriatric patients: focus on clinically relevant non-major bleeding
|
№4 / 2024
|
|
O.A. Zhdanova, G.A. Batishcheva, N.N. Perova, O.A. Mubarakshina, O.V. Cherenkova, E.D. Neyno
Analysis of spontaneous reports of adverse drug reactions in children of different ages
|
№3 / 2024
|
|
A.V. Dubinina, A.I. Kochetkov, A.E. Vorobyova, S.S. Eremina, K.B. Mirzaev, O.D. Ostroumova
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease
|
№14 / 2023
|
|
A.I. Listratov, O.D. Ostroumova, N.L. Lyakhova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 2
|
№11-12 / 2022
|
|
A.I. Listratov, O.D. Ostroumova, A.G. Komarova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 1
|
№6 / 2022
|
|
A.P. Pereverzev (1), O.D. Ostroumova (1, 2), D.A. Sychev (1)
Drug-alcohol interactions: focus on central-acting drugs and analgesics
|
№13 / 2021
|
|
D.A. Sychev (1), O.D. Ostroumova (1, 2), A.P. Pereverzev (1), A.I. Kochetkov (1), T.M. Ostroumova (2), M.V. Klepikova (1), E.Yu. Ebzeeva (1)
Tobacco smoking as a risk factor for the development of drug-induced diseases
|
№5 / 2021
|
|
D.A. Sychev (1), O.D. Ostroumova (1, 2), A.I. Kochetkov (1), A.P. Pereverzev (1), T.M. Ostroumova (2), M.V. Klepikova (1), I.A. Alyautdinova (1), E.Yu. Ebzeeva (1)
Drug-induced diseases: epidemiology and urgency of the problem
|
№5 / 2020
|
|
T.M. Ostroumova (1), O.D. Ostroumova (1, 2), A.I. Kochetkov (2), A.P. Pereverzev (2)
Drug-induced nightmares
|
№9 / 2019
|
|
T.I. Eliseeva (1), E.V. Tush (1), I.I. Balabolkin (2), V.A. Bulgakova (2), N.A. Novikova (3), E.S. Zastelo (3), P.V. Trushanina (1), O.V. Khaletskaya (1), Т.Е. Potemina (1)
ADVERSE DRUG REACTIONS IN CHILDREN
|
№11 / 2017
|
|
E.A. Ushkalova, S.K. Zyryanov
LEVOFLOXACIN: BENEFIT-RISK RATIO
|
№s2-17 / 2017
|
|
K.S.Danilina (1), D.A. Sychev (1), O.V. Golovina (1), E.S.Ilina (1), S.V.Gorbotenkova (2)
FREQUENCY OF PRESCRIPTION OF POTENTIALLY NOT RECOMMENDED DRUGS (ACCORDING «STOPP START» CRITERIA) FOR ELDERLY PATIENTS WHO ARE TREATED IN THE THERAPEUTIC DEPARTMENTS OF HOSPITAL: RESULTS OF PHARMACOEPIDEMIOLOGICAL STUDY
|
№13 / 2015
|
Русский
